A simple methodology for capturing proteins implicated in the development of Alzheimer’s disease and other conditions has been developed by researchers at the University of Bradford and University of Dundee.
The new methodology involves easily trapping proteins that bear a specific modification that can provide potential markers for conditions. The specific modification is based on sugar and when attached to a protein affects how the protein functions. Protein modification is a normal, carefully regulated cellular function, but in some instances this can go wrong.
Alzheimer’s, along with other conditions including cancers, type 2 diabetes, and cardio-vascular disease, is affected by dysregulation (abnormal or imperfect regulation) of these sugar modifications to proteins. Identifying such proteins is a key step in understanding their involvement in these various conditions.
The newly developed methodology could open the way for treatments that target these protein alterations, and ultimately the condition.
Previously, capturing these proteins has been very difficult as the sugar modification was prone to falling off the protein. In order to capture them, researcher’s required highly specialised laboratory equipment and extensive validation of identified proteins. This new method is simple and can be carried out by any laboratory, opening the way to rapid identification of proteins involved in the development of a number of diseases.
It also opens up the possibilities for therapies to be developed to target specific proteins identified as being aberrantly modified in these disease processes.
The methodology involves growing a protein with an engineered tail that grabs the sugar-modified protein only. This can then be added to complex protein mixtures obtained from tissue. The modified tail is then used as a handle to pull out all proteins that bear the sugar modification and so separate those proteins that have the modification from those that do not. These proteins can then be identified using several different routine laboratory techniques.
Dr Ritchie Williamson of the University of Bradford said: “This methodology represents a major step forward. We are now in a position where we can easily trap the proteins we need to target. If we can do this we can then identify the proteins which we think may be involved in the disease process. We also have the potential to find biomarkers, especially in younger people, and to probe different diseases.”
Learn more: New test paves way for potential treatments to target Alzheimer’s and other conditions
The Latest on: Early test for Alzheimer’s
[google_news title=”” keyword=”Early test for Alzheimer’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Early test for Alzheimer’s
- Oasis Or Mirage? Digital Dementia Screening In The Neurology Deserton April 26, 2024 at 12:44 pm
Diagnosis of Alzheimer's and related dementias is broken. As blood tests emerge, what is the role of digital screening tools and neurotechnologies in clinical practice?
- New Alzheimer’s Blood Test Gets FDA Designation, Maker Seeks to Play ‘Important Role’ in Diagnosison April 24, 2024 at 5:24 pm
A new blood test that could help identify Alzheimer’s earlier from healthcare company Roche has received a Breakthrough Device Designation from the U.S.
- Study finds eye test could predict Alzheimer’s before symptoms showon April 22, 2024 at 8:00 pm
In a study published in Scientific Reports, researchers from Loughborough University in the United Kingdom showed that a loss of visual sensitivity could predict Alzheimer’s disease 12 years before ...
- Labcorp, Quest add new blood tests for Alzheimer's, brain tissue damageon April 22, 2024 at 11:16 am
The twin clinical testing giants Labcorp and Quest Diagnostics have each, in the past week, added to their portfolios new blood tests that aim to peek into the workings of the human brain.
- Study explores possible future for early Alzheimer's diagnosticson April 22, 2024 at 12:56 am
Digital memory test and a blood sample - this combination will be tested for its potential to identify early Alzheimer's disease in a new research study. Over a hundred healthcare centers are part of ...
- Alzheimer's: I know I'm going to have early onset dementiaon April 20, 2024 at 11:04 pm
James Bexon was just 33 when he was told he had between 20 and 30 years before developing Alzheimer's. His father was diagnosed at 58, and in 2018 James took an NHS test which said he had a 99.9% ...
- Detecting Alzheimer’s disease early through Roche’s breakthrough FDA approved blood teston April 20, 2024 at 4:39 am
A test to detect Alzheimer’s disease earlier is one step closer after receiving the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) ...
- Do I have dementia and how to test for iton April 19, 2024 at 12:00 am
Getting a dementia diagnosis is a long and complicated process, which can be a postcode lottery. In some cases where patients are under 65, it can take four years from recognising symptoms to ...
- Could a simple eye test predict Alzheimer's 12 years before symptoms show?on April 18, 2024 at 6:00 am
A recent study suggests that people with poor vision sensitivity are more likely to go on and develop Alzheimer's disease, and that a simple eye test could help predict the onset of this condition.
via Bing News